InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.41%
)
US TECH 100
19,528.00
(
0.90%
)
Dow Jones
42,052.19
(
0.69%
)
Brent Oil
72.91
(
0.00%
)
Bitcoin
69,545.00
(
0.09%
)
Post# of 253509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sdtrond

Send PM Follow Ignore
Followers 11
Posts 116
Boards Moderated 0
Alias Born 02/15/2010

sdtrond

Re: iwfal post# 95091

Monday, 05/03/2010 10:41:04 AM

Monday, May 03, 2010 10:41:04 AM

Post# of 253509
iwfal,

Trond>>
I still find it curious how anyone can make the case that this particular drug has marginal efficacy?

iwfal>>
Because I think you'd be hard pressed to find many onc drug with an HR>0.75 that made more than $1B/Yr in any given single indication...

I asked about this particular drug and you go off to "many onc drugs". I wasn't asking about revenue estimates.

Based on IMPACT data and looking at prior trial data, my question still stands: how can you make the case that this particular drug has marginal efficacy?

Regards,
Trond
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up